Home LiteratureArticle Details
PMID: 12147437 Published · ppublish English Journal Article Review

Stem-cell origin of metastasis and heterogeneity in solid tumours.

The Lancet. Oncology ·Vol. 3 ·No. 8 ·2002-08-00 ·Pages 508-13

Tu SM, Lin SH, Logothetis CJ

Abstract

An explanation for the inherently metastatic and heterogeneous nature of cancers may be their derivation from distinct stem cells. The type of stem cell from which a neoplasm arises determines both the metastatic potential and the phenotypic diversity of that neoplasm. Hence, tumours originating from an early stem cell or its progenitor cells metastasise readily and have a more heterogeneous phenotype, whereas tumours originating from a later stem cell or its progenitor cells have limited metastatic potential and a more homogeneous phenotype. Further investigation of the role of stem cells in the development of cancer may lead to the discovery of novel diagnostic tools, prognostic markers, and therapeutic targets in the battle against cancer.

MeSH Terms
Biomarkers, Tumor/analysis Genetic Predisposition to Disease Hematologic Neoplasms/genetics,pathology Humans Immunohistochemistry Neoplasm Invasiveness Neoplasm Metastasis/pathology Neoplasms/genetics,pathology Neoplastic Stem Cells/pathology Phenotype Sensitivity and Specificity
Chemicals
Biomarkers, Tumor
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tu Shi-Ming
Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. stu@notes.mdacc.tmc.edu
Lin Sue-Hwa
Logothetis Christopher J
Article Info
Journal
The Lancet. Oncology
Abbr.
Lancet Oncol
ISSN
1470-2045
Published
2002-08-00
Pages
508-13
Language
English
Region
England
NLM ID
100957246
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com